MedTrace Logo

Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial

NCT01799629 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2024-03-06

No results posted yet for this study

Summary

To evaluate the efficacy of prophylactic glycerin suppositories will accelerate the elimination of meconium from the large intestine and thus reduce the incidence of feeding intolerance in very low birth weight (VLBW) infants

Conditions

  • Infant, Very Low Birth Weight

Interventions

DRUG

Glycerin suppositories

Sponsors & Collaborators

  • Dr. Sulaiman Alhabib Medical City, Riyadh

    collaborator OTHER

  • Security Forces Hospital

    collaborator OTHER

  • King Faisal Specialist Hospital & Research Center

    lead OTHER

Principal Investigators

  • Emad M Khadawardi, MD · King Faisal Specialist Hospital & Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
1 Month
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01799629 on ClinicalTrials.gov